Terms: = Ovarian cancer AND FLT4, FLT41, 2324, ENSG00000037280, P35916, VEGFR3, PCL
90 results:
1. Biodegradable Local Chemotherapy Platform with Prolonged and Controlled Release of Doxorubicin for the Prevention of Local Tumor Recurrence.
Voznyuk AA; Makarets YA; Advakhova DY; Khafizov KA; Lugovoi ME; Zakharova VA; Senatov FS; Koudan EV
ACS Appl Bio Mater; 2024 Apr; 7(4):2472-2487. PubMed ID: 38480461
[TBL] [Abstract] [Full Text] [Related]
2. Biomarker Testing Journey Among Patients with Advanced Solid Tumors and Treatment Patterns by Homologous Recombination Repair Status: A Clinico-Genomic Database Study.
Shao C; Ren Y; Zhou H; Lee LC; Chen C; Dettman EJ; Cristescu R; Gozman A; Jin F; Zhou W
Adv Ther; 2024 Feb; 41(2):759-776. PubMed ID: 38169059
[TBL] [Abstract] [Full Text] [Related]
3. Anticancer Evaluation of Methoxy Poly(Ethylene Glycol)-
Shin YB; Choi JY; Shin DH; Lee JW
Int J Nanomedicine; 2023; 18():2209-2223. PubMed ID: 37152471
[TBL] [Abstract] [Full Text] [Related]
4. vegfr3 suppression through miR-1236 inhibits proliferation and induces apoptosis in ovarian cancer via ERK1/2 and AKT signaling pathways.
Babaei Z; Panjehpour M; Ghorbanhosseini SS; Parsian H; Khademi M; Aghaei M
J Cell Biochem; 2023 May; 124(5):674-686. PubMed ID: 36922713
[TBL] [Abstract] [Full Text] [Related]
5. LncRNA H19 promotes tumor angiogenesis in smokers by targeting anti-angiogenic miRNAs.
Shirvaliloo M
Epigenomics; 2023 Jan; 15(2):61-73. PubMed ID: 36802727
[TBL] [Abstract] [Full Text] [Related]
6. Molecular mechanisms of miR-1236 in the assessment of tumor lymphangiogenesis in human ovarian cancer patients.
Khademi M; Babaei Z; Ghorbanhosseini SS; Emami Razavi A; Aghaei M
J Gene Med; 2023 May; 25(5):e3480. PubMed ID: 36750632
[TBL] [Abstract] [Full Text] [Related]
7. Development, Characterization, and In Vitro Evaluation of Cytotoxic Activity of Rutin Loaded pcl-PEG Nanoparticles Against Skov3 ovarian cancer Cell.
Firouzai-Amandi A; Tarahomi M; Rahmani Youshanlouie H; Mosaddeghi Heris R; Jafari-Gharabaghlou D; Zarghami N; Dadashpour M
Asian Pac J Cancer Prev; 2022 Jun; 23(6):1951-1957. PubMed ID: 35763636
[TBL] [Abstract] [Full Text] [Related]
8. Construction of a New Dual-Responsive Nano-Drug Delivery System for Matrix Metalloproteinases and Adenosine Triphosphate in ovarian cancer Using Nanomicelles.
Li G; Xu W; Shi Y; Chen M; Peng D
J Biomed Nanotechnol; 2022 Mar; 18(3):718-728. PubMed ID: 35715904
[TBL] [Abstract] [Full Text] [Related]
9. Inflammatory markers in women with reported benign gynecologic pathology: an analysis of the Prostate, Lung, Colorectal and ovarian cancer Screening Trial.
King LA; Wentzensen N; Purdue MP; Katki HA; Pinto LA; Trabert B
Ann Epidemiol; 2022 Apr; 68():1-8. PubMed ID: 34906633
[TBL] [Abstract] [Full Text] [Related]
10. Tumor-Targeting Polycaprolactone Nanoparticles with Codelivery of Paclitaxel and IR780 for Combinational Therapy of Drug-Resistant ovarian cancer.
Pan Q; Tian J; Zhu H; Hong L; Mao Z; Oliveira JM; Reis RL; Li X
ACS Biomater Sci Eng; 2020 Apr; 6(4):2175-2185. PubMed ID: 33455308
[TBL] [Abstract] [Full Text] [Related]
11. Acyl and oligo(lactic acid) prodrugs for PEG-b-PLA and PEG-b-pcl nano-assemblies for injection.
Repp L; Rasoulianboroujeni M; Lee HJ; Kwon GS
J Control Release; 2021 Feb; 330():1004-1015. PubMed ID: 33166607
[TBL] [Abstract] [Full Text] [Related]
12. Combination of PARP Inhibitor Olaparib, and PD-L1 Inhibitor Durvalumab, in Recurrent ovarian cancer: a Proof-of-Concept Phase II Study.
Lampert EJ; Zimmer A; Padget M; Cimino-Mathews A; Nair JR; Liu Y; Swisher EM; Hodge JW; Nixon AB; Nichols E; Bagheri MH; Levy E; Radke MR; Lipkowitz S; Annunziata CM; Taube JM; Steinberg SM; Lee JM
Clin Cancer Res; 2020 Aug; 26(16):4268-4279. PubMed ID: 32398324
[TBL] [Abstract] [Full Text] [Related]
13. BACH family members regulate angiogenesis and lymphangiogenesis by modulating VEGFC expression.
Cohen B; Tempelhof H; Raz T; Oren R; Nicenboim J; Bochner F; Even R; Jelinski A; Eilam R; Ben-Dor S; Adaddi Y; Golani O; Lazar S; Yaniv K; Neeman M
Life Sci Alliance; 2020 Apr; 3(4):. PubMed ID: 32132179
[TBL] [Abstract] [Full Text] [Related]
14. Improving the Anti-ovarian cancer Activity of Docetaxel by Self-Assemble Micelles and Thermosensitive Hydrogel Drug Delivery System.
Xu G; Zhu C; Li B; Wang T; Wan J; Zhang Y; Huang J; Yang D; Shen Y
J Biomed Nanotechnol; 2020 Jan; 16(1):40-53. PubMed ID: 31996284
[TBL] [Abstract] [Full Text] [Related]
15. Primary Preclinical and Clinical Evaluation of
Li F; Zhang Z; Cai J; Chen X; Zhou Y; Ma X; Dong Q; Li F; Xi L
Clin Cancer Res; 2020 Mar; 26(6):1318-1326. PubMed ID: 31843751
[TBL] [Abstract] [Full Text] [Related]
16. Antisense LNA-loaded nanoparticles of star-shaped glucose-core pcl-PEG copolymer for enhanced inhibition of oncomiR-214 and nucleolin-mediated therapy of cisplatin-resistant ovarian cancer cells.
Vandghanooni S; Eskandani M; Barar J; Omidi Y
Int J Pharm; 2020 Jan; 573():118729. PubMed ID: 31705975
[TBL] [Abstract] [Full Text] [Related]
17. Micelles via self-assembly of amphiphilic beta-cyclodextrin block copolymers as drug carrier for cancer therapy.
Li X; Liu H; Li J; Deng Z; Li L; Liu J; Yuan J; Gao P; Yang Y; Zhong S
Colloids Surf B Biointerfaces; 2019 Nov; 183():110425. PubMed ID: 31421407
[TBL] [Abstract] [Full Text] [Related]
18. Interobserver agreement among expert pathologists on through-the-needle microforceps biopsy samples for evaluation of pancreatic cystic lesions.
Larghi A; Manfrin E; Fabbri C; Crinò SF; Correale L; Chiarello G; Barresi L; Van Velthuysen ML; Poley JW; Rahal D; Carrara S; Inzani F; Fornelli A
Gastrointest Endosc; 2019 Nov; 90(5):784-792.e4. PubMed ID: 31323232
[TBL] [Abstract] [Full Text] [Related]
19. Expression profiles of VEGF-A, VEGF-D and VEGFR1 are higher in distant metastases than in matched primary high grade epithelial ovarian cancer.
Sopo M; Anttila M; Hämäläinen K; Kivelä A; Ylä-Herttuala S; Kosma VM; Keski-Nisula L; Sallinen H
BMC Cancer; 2019 Jun; 19(1):584. PubMed ID: 31200683
[TBL] [Abstract] [Full Text] [Related]
20. Microfluidic Assembly of siRNA-Loaded Micelleplexes for Tumor Targeting in an Orthotopic Model of ovarian cancer.
Feldmann DP; Jones S; Douglas K; Shields AF; Merkel OM
Methods Mol Biol; 2019; 1974():355-369. PubMed ID: 31099014
[TBL] [Abstract] [Full Text] [Related]
[Next]
